Transcenta
Huangpu
About Transcenta
Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture, focusing on developing innovative antibodies to help more patients. HJB and MabSpace Biosciences merged and created Transcenta.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $342.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Nov 2021)
- Ticker: hkg:6628
- Website: transcenta.com
- Phone: 0571-28279502
Industries & Categories
Biopharma, Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/transcenta-50318 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.